Cargando…

Cell-Type Specific Deletion of CB2 Cannabinoid Receptors in Dopamine Neurons Induced Hyperactivity Phenotype: Possible Relevance to Attention-Deficit Hyperactivity Disorder

DAT-Cnr2 mice are conditional knockout (cKO) animals that do not express cannabinoid CB2 receptors (CB2R), in midbrain dopamine neurons. The hyperactivity phenotype of DAT-Cnr2 cKO mice were paradoxically reduced by low dose of amphetamine. Here, we report on the locomotor activity analysis in male...

Descripción completa

Detalles Bibliográficos
Autores principales: Canseco-Alba, Ana, Sanabria, Branden, Hammouda, Mariam, Bernadin, Rollanda, Mina, Marizel, Liu, Qing-Rong, Onaivi, Emmanuel S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860836/
https://www.ncbi.nlm.nih.gov/pubmed/35211038
http://dx.doi.org/10.3389/fpsyt.2021.803394
_version_ 1784654761850568704
author Canseco-Alba, Ana
Sanabria, Branden
Hammouda, Mariam
Bernadin, Rollanda
Mina, Marizel
Liu, Qing-Rong
Onaivi, Emmanuel S.
author_facet Canseco-Alba, Ana
Sanabria, Branden
Hammouda, Mariam
Bernadin, Rollanda
Mina, Marizel
Liu, Qing-Rong
Onaivi, Emmanuel S.
author_sort Canseco-Alba, Ana
collection PubMed
description DAT-Cnr2 mice are conditional knockout (cKO) animals that do not express cannabinoid CB2 receptors (CB2R), in midbrain dopamine neurons. The hyperactivity phenotype of DAT-Cnr2 cKO mice were paradoxically reduced by low dose of amphetamine. Here, we report on the locomotor activity analysis in male and female adolescent (PND 30 ± 2) mice in basal conditions and in response to different doses of amphetamine, using the Open Field (OF), Elevated Plus-Maze (EPM) tests and the Novel Object Recognition (NOR) task as a putative model of attention deficit hyperactivity disorder (ADHD). Results showed that both male and female adolescent DAT-Cnr2 mice displayed significant increases in distance traveled in the OF test compared with WT mice. However, 2 mg/kg dose of amphetamine reduced the distance traveled by the DAT-Cnr2 but was increased in the WT mice. In the EPM test of anxiety-like behavioral responses, DAT-Cnr2 spent more time in the open arms of the maze than the WT mice, suggesting a reduction in anxiety-like response. DAT-Cnr2 mice showed significant increase in the number of unprotected head dips in the maze test and in the cliff avoidance reaction (CAR) test demonstrating impulsivity and risky behavior. DAT-Cnr2 mice also exhibited deficient response in the delay decision making (DDM), with impulsive choice. Both DAT-Cnr2 and WT were able to recognize the new object in the NOR task, but the exploration by the DAT-Cnr2 was less than that of the WT mice. Following the administration of 2 mg/kg of amphetamine, the similarities and differential performances of the DAT-Cnr2 and WT mice in the EPM test and NOR task was probably due to increase in attention. Microglia activation detected by Cd11b immunolabelling was enhanced in the hippocampus in DAT-Cnr2 cKO than in WT mice, implicating neuro-immune modulatory effects of CB2R. The results demonstrates that DAT-Cnr2 cKO mice with cell-type specific deletion of CB2R in midbrain dopaminergic neurons may represent a possible model for studying the neurobiological basis of ADHD.
format Online
Article
Text
id pubmed-8860836
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88608362022-02-23 Cell-Type Specific Deletion of CB2 Cannabinoid Receptors in Dopamine Neurons Induced Hyperactivity Phenotype: Possible Relevance to Attention-Deficit Hyperactivity Disorder Canseco-Alba, Ana Sanabria, Branden Hammouda, Mariam Bernadin, Rollanda Mina, Marizel Liu, Qing-Rong Onaivi, Emmanuel S. Front Psychiatry Psychiatry DAT-Cnr2 mice are conditional knockout (cKO) animals that do not express cannabinoid CB2 receptors (CB2R), in midbrain dopamine neurons. The hyperactivity phenotype of DAT-Cnr2 cKO mice were paradoxically reduced by low dose of amphetamine. Here, we report on the locomotor activity analysis in male and female adolescent (PND 30 ± 2) mice in basal conditions and in response to different doses of amphetamine, using the Open Field (OF), Elevated Plus-Maze (EPM) tests and the Novel Object Recognition (NOR) task as a putative model of attention deficit hyperactivity disorder (ADHD). Results showed that both male and female adolescent DAT-Cnr2 mice displayed significant increases in distance traveled in the OF test compared with WT mice. However, 2 mg/kg dose of amphetamine reduced the distance traveled by the DAT-Cnr2 but was increased in the WT mice. In the EPM test of anxiety-like behavioral responses, DAT-Cnr2 spent more time in the open arms of the maze than the WT mice, suggesting a reduction in anxiety-like response. DAT-Cnr2 mice showed significant increase in the number of unprotected head dips in the maze test and in the cliff avoidance reaction (CAR) test demonstrating impulsivity and risky behavior. DAT-Cnr2 mice also exhibited deficient response in the delay decision making (DDM), with impulsive choice. Both DAT-Cnr2 and WT were able to recognize the new object in the NOR task, but the exploration by the DAT-Cnr2 was less than that of the WT mice. Following the administration of 2 mg/kg of amphetamine, the similarities and differential performances of the DAT-Cnr2 and WT mice in the EPM test and NOR task was probably due to increase in attention. Microglia activation detected by Cd11b immunolabelling was enhanced in the hippocampus in DAT-Cnr2 cKO than in WT mice, implicating neuro-immune modulatory effects of CB2R. The results demonstrates that DAT-Cnr2 cKO mice with cell-type specific deletion of CB2R in midbrain dopaminergic neurons may represent a possible model for studying the neurobiological basis of ADHD. Frontiers Media S.A. 2022-02-08 /pmc/articles/PMC8860836/ /pubmed/35211038 http://dx.doi.org/10.3389/fpsyt.2021.803394 Text en Copyright © 2022 Canseco-Alba, Sanabria, Hammouda, Bernadin, Mina, Liu and Onaivi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Canseco-Alba, Ana
Sanabria, Branden
Hammouda, Mariam
Bernadin, Rollanda
Mina, Marizel
Liu, Qing-Rong
Onaivi, Emmanuel S.
Cell-Type Specific Deletion of CB2 Cannabinoid Receptors in Dopamine Neurons Induced Hyperactivity Phenotype: Possible Relevance to Attention-Deficit Hyperactivity Disorder
title Cell-Type Specific Deletion of CB2 Cannabinoid Receptors in Dopamine Neurons Induced Hyperactivity Phenotype: Possible Relevance to Attention-Deficit Hyperactivity Disorder
title_full Cell-Type Specific Deletion of CB2 Cannabinoid Receptors in Dopamine Neurons Induced Hyperactivity Phenotype: Possible Relevance to Attention-Deficit Hyperactivity Disorder
title_fullStr Cell-Type Specific Deletion of CB2 Cannabinoid Receptors in Dopamine Neurons Induced Hyperactivity Phenotype: Possible Relevance to Attention-Deficit Hyperactivity Disorder
title_full_unstemmed Cell-Type Specific Deletion of CB2 Cannabinoid Receptors in Dopamine Neurons Induced Hyperactivity Phenotype: Possible Relevance to Attention-Deficit Hyperactivity Disorder
title_short Cell-Type Specific Deletion of CB2 Cannabinoid Receptors in Dopamine Neurons Induced Hyperactivity Phenotype: Possible Relevance to Attention-Deficit Hyperactivity Disorder
title_sort cell-type specific deletion of cb2 cannabinoid receptors in dopamine neurons induced hyperactivity phenotype: possible relevance to attention-deficit hyperactivity disorder
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860836/
https://www.ncbi.nlm.nih.gov/pubmed/35211038
http://dx.doi.org/10.3389/fpsyt.2021.803394
work_keys_str_mv AT cansecoalbaana celltypespecificdeletionofcb2cannabinoidreceptorsindopamineneuronsinducedhyperactivityphenotypepossiblerelevancetoattentiondeficithyperactivitydisorder
AT sanabriabranden celltypespecificdeletionofcb2cannabinoidreceptorsindopamineneuronsinducedhyperactivityphenotypepossiblerelevancetoattentiondeficithyperactivitydisorder
AT hammoudamariam celltypespecificdeletionofcb2cannabinoidreceptorsindopamineneuronsinducedhyperactivityphenotypepossiblerelevancetoattentiondeficithyperactivitydisorder
AT bernadinrollanda celltypespecificdeletionofcb2cannabinoidreceptorsindopamineneuronsinducedhyperactivityphenotypepossiblerelevancetoattentiondeficithyperactivitydisorder
AT minamarizel celltypespecificdeletionofcb2cannabinoidreceptorsindopamineneuronsinducedhyperactivityphenotypepossiblerelevancetoattentiondeficithyperactivitydisorder
AT liuqingrong celltypespecificdeletionofcb2cannabinoidreceptorsindopamineneuronsinducedhyperactivityphenotypepossiblerelevancetoattentiondeficithyperactivitydisorder
AT onaiviemmanuels celltypespecificdeletionofcb2cannabinoidreceptorsindopamineneuronsinducedhyperactivityphenotypepossiblerelevancetoattentiondeficithyperactivitydisorder